| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/10/2004 | WO2004031397A3 Detection of evolutionary bottlenecking by dna sequencing as a method to discover genes of value |
| 09/10/2004 | WO2004030622A3 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 09/10/2004 | WO2004025253A3 Method of visualizing proteins bound to protein-binding membranes |
| 09/10/2004 | WO2004023867A3 Transgenic cancer models in fish |
| 09/10/2004 | WO2004023170A3 Bioanalysis systems including optical integrated circuit |
| 09/10/2004 | WO2004021144A3 Systems and methods for inferring biological networks |
| 09/10/2004 | WO2004020973A3 Screening for cell-targeting ligands attached to metal nanoshells for use in target-cell killing |
| 09/10/2004 | WO2004019886A3 Methods for up-regulating antigen expression in tumors |
| 09/10/2004 | WO2004018995A3 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibodies and other binding agents |
| 09/10/2004 | WO2004015420A8 Method for diagnosing multiple sclerosis |
| 09/10/2004 | WO2004012847A3 Sim2 polypeptides and polynucleotides and uses of each in diagnosis and treatment of ovarian, breast and lung cancers |
| 09/10/2004 | WO2004009759A3 Novel proteins in enteroaggregative escherichia coli (eaec) useful for diagnosis and therapy of eaec infections |
| 09/10/2004 | WO2003106970A3 P27 prevents cellular migration |
| 09/10/2004 | WO2003095977A3 Methods for cancer prognosis and diagnosis relating to tumor vascular endothelial cells |
| 09/10/2004 | WO2003094844A3 Prostate cancer-related compositions, methods, and kits based on dna macroarray proteomics platforms |
| 09/10/2004 | WO2003091397A3 Methods and compositions for regulating cellular signaling |
| 09/10/2004 | WO2003088125A3 System and method for integrated computer-aided molecular discovery |
| 09/10/2004 | WO2003087123A3 Methods and kits for testing mutagenicity |
| 09/10/2004 | WO2003084982A3 Functionalized compositions for improved immobilization |
| 09/10/2004 | WO2003078449A3 A rapid and sensitive proximity-based assay for the detection and quantification of dna binding proteins |
| 09/10/2004 | WO2003065146A3 Methods for placing, accepting, and filling orders for products and services |
| 09/10/2004 | WO2003045230A3 Novel compositions and methods for cancer |
| 09/10/2004 | WO2003028539A3 Materials and methods for the diagnosis of pediatric tumors |
| 09/10/2004 | WO2003003979A3 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| 09/10/2004 | WO2002098890A3 MARKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 09/10/2004 | WO2002094981A3 Method of identifying peptides capable of binding to mhc molecules, peptides identified thereby and their uses |
| 09/10/2004 | WO2002094780A3 Kinases and phosphatases |
| 09/10/2004 | WO2002011048A3 Visualization and manipulation of biomolecular relationships using graph operators |
| 09/10/2004 | CA2519193A1 Methods for the early diagnosis of ovarian cancer |
| 09/10/2004 | CA2517834A1 Method for selecting a candidate drug compound |
| 09/10/2004 | CA2517349A1 Library of compounds labelled with radioisotope |
| 09/10/2004 | CA2517082A1 Clinically relevant animal model of human breast cancer and vegf involvement in desmoplastic response |
| 09/10/2004 | CA2517076A1 Serum macrophage migration inhibitory factor (mif) as marker for prostate cancer |
| 09/10/2004 | CA2517074A1 Nucleic acid molecules, polypeptides, antibodies and compositions containing same useful for treating and detecting influenza virus infection |
| 09/10/2004 | CA2516795A1 Circulating tumor cells (ctc's): early assessment of time to progression,_survival and response to therapy in metastatic cancer patients |
| 09/10/2004 | CA2516750A1 Knockout identification of target-specific sites in peptides |
| 09/10/2004 | CA2516653A1 Serotonin and catecholamine system segment optimization technology |
| 09/10/2004 | CA2516651A1 Methods of screening for trpm5 modulators |
| 09/10/2004 | CA2516591A1 Multiple marker assay for detection of ovarian cancer |
| 09/10/2004 | CA2516588A1 Assay for detection of renal cell carcinoma |
| 09/10/2004 | CA2516579A1 Method of detecting onset risk of encephalitis or encephalopathy |
| 09/10/2004 | CA2516563A1 Methods of preventing, treating and diagnosing disorders of protein aggregation |
| 09/10/2004 | CA2516546A1 Dry chemistry, lateral flow-reconstituted chromatographic enzyme-driven assays |
| 09/10/2004 | CA2515588A1 Apparatus and method for machining microchamber for cell culture |
| 09/10/2004 | CA2515389A1 Monoclonal antibody and gene encoding the same, hybridoma, pharmaceutical compostion, and diagnostic reagent |
| 09/10/2004 | CA2514329A1 Methods for the treatment of renal cell carcinoma |
| 09/09/2004 | US20040177396 Genetically engineered cleft palate rodent model comprising vector coding fluorescent reporter wherein gamma -aminobutyric acid neurons can be visualized in vivo; tissue engineering and diagnostic analysis |
| 09/09/2004 | US20040177388 Methods and compositions for the identification and treatment of neurodegenerative disorders |
| 09/09/2004 | US20040177387 Using mutation in gene associated with monocyte chemoattractant protein-1detect, diagnose, prevent and treat vision disorders |
| 09/09/2004 | US20040176929 Monitoring and maintaining equipment and machinery |
| 09/09/2004 | US20040176914 detecting the presence or amount of one or more biologically active natriuretic peptides of interest in a sample |
| 09/09/2004 | US20040176705 Cartridge having an integrated collection element for point of care system |
| 09/09/2004 | US20040176704 Collection device adapted to accept cartridge for point of care system |
| 09/09/2004 | US20040176701 Apparatus for inspecting allergic reaction |
| 09/09/2004 | US20040176669 Optical-based sensing devices |
| 09/09/2004 | US20040176625 Kinesin motor modulators derived from the marine sponge Adocia |
| 09/09/2004 | US20040176599 Generating chemiluminescence by reaction with peroxidase compound and detection of signal with analyzing compound |
| 09/09/2004 | US20040176586 Process for detecting the presence or quantity of enzymatic activity in a sample |
| 09/09/2004 | US20040176585 Using mass spectroscopy to accurately determine sequence of biopolymers; sequence determination |
| 09/09/2004 | US20040176578 Amino acid sequences capable of associating with fluorophore dyes for use as diagnostic tools in vitro and invivo detection and assay systems |
| 09/09/2004 | US20040176577 Immunoassays for specific determination of SCCA isoforms |
| 09/09/2004 | US20040176575 Compounds comprising modified secondary ligand binding site for treatment and prevention of infections, diabetes, emphysema, viral, endocrine and cell proliferative disorders |
| 09/09/2004 | US20040176573 Major histocompatibility complex class I restricted epitope peptide for use in diagnosis, prevention and treament of cell proliferative disorders; antitumor agents |
| 09/09/2004 | US20040176570 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
| 09/09/2004 | US20040176397 (Oxo-Pyrazolo[1,5a]pyrimidin-2-yl)Alkyl-Carboxamides |
| 09/09/2004 | US20040176314 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
| 09/09/2004 | US20040176313 Inhibitors of Src kinase for use in alzheimer's disease |
| 09/09/2004 | US20040176304 arginine-threonine-arginine (RTR) peptide complexed with N-acetyl-Proline-Glycine-Proline; autoimmune diseases: chronic inflammatory bowel diease, rheumatoid arthritis; heart ischemia; Adult respiratory distress syndromes: asthma, emphysema |
| 09/09/2004 | US20040176298 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 09/09/2004 | US20040176293 Methods for screening, treating and diagnosing inflammatory bowel disease and compositions thereof |
| 09/09/2004 | US20040176290 Anti-angiogenic state in mice and humans with retinal photorecptor cell degeneration |
| 09/09/2004 | US20040176261 Lubricant composition and analysis method for same |
| 09/09/2004 | US20040175843 made from micropattemed microbead material in the form of a polymeric substrate which is etched or lithographycally divided and separated |
| 09/09/2004 | US20040175842 Near-field and far-field encoding of microbeads for bioassays |
| 09/09/2004 | US20040175841 Detection and amplification of ligands |
| 09/09/2004 | US20040175839 kit includes at least two compounds of different molecular mass, one above, one below and both close to the expected molecular mass of the material whose exact mass is to be measured; calibration curve is not linear |
| 09/09/2004 | US20040175836 for fluorescence resonance energy transfer (FRET) for the qualitative and/or quantitative determination of a liquid measuring medium |
| 09/09/2004 | US20040175835 for determining the risk of flammability of a mixture of two reactive gases in an inert or base gas using computer programs |
| 09/09/2004 | US20040175834 for monitoring efficacy and toxicity of cancer chemotherapy using mass spectrometry/spectrophotometry |
| 09/09/2004 | US20040175822 Apparatus and method for edman degradation using a microfluidic system |
| 09/09/2004 | US20040175803 Interferon-alpha induced gene |
| 09/09/2004 | US20040175791 DcR3 polypeptide, a TNFR homolog |
| 09/09/2004 | US20040175789 for drug screening asthma, chronic obstructive pulmonary disease, emphysema, chronic bronchitis, acute respiratory distress syndrome, cough and acute bronchitis drugs; genetic engineering |
| 09/09/2004 | US20040175787 for treating spastcity, trigeminal neuralgia, asthma, cough, emesis, ulcers, urinary incontinence and cocaine addiction |
| 09/09/2004 | US20040175776 Assay method for platelet-activating factor |
| 09/09/2004 | US20040175775 feature the decreased presence of antigen-binding factors, which could block antibody-antigen interactions; for medicine /veterinary medicine |
| 09/09/2004 | US20040175774 Method for predicting the sensitivity to chemotherapy |
| 09/09/2004 | US20040175773 Screening method based on siah-numb interaction |
| 09/09/2004 | US20040175772 for drug screening cancer drugs and tumor activators/suppressors; fluorescence resonance energy transfer; genetic engineering |
| 09/09/2004 | US20040175771 At-home cancer test |
| 09/09/2004 | US20040175770 by inducing or mimicking human gene activity causing the degradation of beta -catenin using genetically engineered cells/ animal models |
| 09/09/2004 | US20040175769 comprising contacting a reagent containing hyaluronic acid binding protein modified with a labeled substance (a labeled hyaluronic acid binding protein) with a sample containing hyaluronic acid to form a complex; kits |
| 09/09/2004 | US20040175768 Sensor for use in biological recognition; complexing biotinylated fluorescent polymer and a biotin-binding protein in aqueous solution |
| 09/09/2004 | US20040175767 for lightening or darkening the pigmentation of cells and tissue (skin) in cells/cell-free systems; for drug screening |
| 09/09/2004 | US20040175766 Human pyrimidine receptor |
| 09/09/2004 | US20040175765 Cell-screening assay and composition |
| 09/09/2004 | US20040175764 comprises plurality of thumbnail images included in images stored in the personal computer displayed in an array in a browse mode |
| 09/09/2004 | US20040175763 Branched multiple antigenic peptide for accurate diagnosis of inflammatory bowel disorders |
| 09/09/2004 | US20040175762 Screening system based on expression of abcg2 half transporter protein |
| 09/09/2004 | US20040175761 Voltage sensor domains of voltage-dependent ion channel proteins and uses thereof |